Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
47°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amneal Pharmaceuticals Inc
(NY:
AMRX
)
5.870
UNCHANGED
Last Price
Updated: 7:00 PM EST, Dec 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amneal Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
Next >
Amneal Reports Certain Preliminary Third Quarter 2023 Financial Results and Raises Full Year 2023 Financial Guidance
October 23, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Adds Two Denosumab Biosimilars to U.S. Pipeline, Expanding Oncology Portfolio
October 12, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday
October 06, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Friday. Here are some big stocks recording gains in Friday's session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Amneal to Report Third Quarter 2023 Results on November 7, 2023
October 05, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Analyst Ratings for Amneal Pharmaceuticals
September 06, 2023
Via
Benzinga
Amneal Pharmaceuticals's Earnings: A Preview
August 03, 2023
Via
Benzinga
Why Shares of Amneal Pharmaceuticals Are Plunging Wednesday
July 05, 2023
The company received a complete response letter from the FDA regarding a Parkinson's disease generic therapy.
Via
The Motley Fool
Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection
September 06, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Receives First Product Approval in China
September 06, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate
September 06, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Delegation from U.S. Department of Health and Human Services, U.S. Food and Drug Administration, and Local Government Officials Visit Amneal Manufacturing Site in India
August 29, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal to Participate at the 2023 Wells Fargo Healthcare Conference
August 25, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
JAMA Neurology Publishes Phase 3 Study Results Comparing IPX203 to Immediate-Release Carbidopa/Levodopa for Parkinson’s Disease
August 24, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
August 04, 2023
Via
Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
August 04, 2023
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
Via
Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
August 04, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Amneal Pharmaceuticals Stock Gaines: It Raised FY23 Outlook On Prescription Trends, Pricing Levels Strength
August 04, 2023
Amneal Pharmaceuticals Inc (NYSE: AMRX) reports Q2 revenue of $599 million, an increase of 7% Y/Y, beating the consensus of $5
Via
Benzinga
Amneal Reports Second Quarter 2023 Financial Results
August 04, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Earnings Scheduled For August 4, 2023
August 04, 2023
Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter.
Via
Benzinga
Amneal Submits Abbreviated New Drug Applications to U.S. FDA for Three Key Complex Generics
July 26, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal to Report Second Quarter 2023 Results on August 4, 2023
July 06, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Crude Oil Rises Sharply; Impel Pharmaceuticals Shares Spike Higher
July 05, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 50 points on Wednesday. The Dow traded down 0.17% to 34,361.31 while the NASDAQ fell 0.14% to 13,797.72. The S&P 500,...
Via
Benzinga
Dow Drops 150 Points; US Factory Orders Increase 0.3% In May
July 05, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.46% to 34,259.45 while the NASDAQ fell...
Via
Benzinga
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 05, 2023
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 05, 2023
Via
Benzinga
FDA Strikes Out Amneal Pharmaceuticals' Parkinson's Disease Candidate, Stock Falls
July 05, 2023
Amneal Pharmaceuticals Inc (NYSE: AMRX) received an FDA Complete Response Letter (CRL) regarding its New Drug Application for IPX203
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 04, 2023
Via
Benzinga
Amneal Launches Authorized Generic for Xyrem® (sodium oxybate) and Receives FDA Approval for Five Complex Generics in the Second Quarter
July 03, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Receives U.S. FDA Complete Response Letter for IPX203
July 03, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Releases 2022 Environmental, Social and Governance Report Mapped to the United Nations Sustainable Development Goals
June 15, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.